baber/WOPTO huggingface dataset:
Patent AU-2021230003-A1 (AU)
Title: Improved turbine and blade for the protection of the root from flow path hot gases
Inventor: DI SISTO PAOLO
IPC: F01D11/04
Filed: 2021-02-22
Abstract: A urbine (14), and particularly a low pressure turbine is disclosed, which comprises a plurality of rotor members (2) and spacers for arranged between rotor members, to avoid that an ingested gas flow from the hot gas flow path channel (F) reaches the wheel space (5). The rotor members each include a deflector (8). The deflector is placed in correspondence with each spacer and deflects the ingested gas flow over the upper surface of the spacer, thus preventing it to heat up the roots of the blades (4).
Patent AU-2021236725-A1 (AU)
Title: Communication method and device in uplink coordination
Inventor: LI YUNBO
IPC: H04W28/16
Filed: 2021-03-10
Abstract: Disclosed in embodiments of the present application are a communication method and device in uplink coordination, which can be applied to uplink coordination scenarios of multiple WiFi standards. In the method provided by the embodiments of the present application, a trigger frame generated by a first access point may comprise: identifier information of multiple basic service sets (BSSs) and identifier information of stations. The trigger frame may trigger multiple BSSs for uplink coordination. Moreover, for the first access point, identifiers of stations triggered in the BSSs can be carried in the trigger frame, and therefore, the first access point may independently configure identifier information of stations associated with the first access point, without ensuring that identifiers of the stations of the multiple BSSs are unique, so that the flexibility of the first access point to configure the identifier information of the triggered stations is increased, and the communication between an access point and stations in an uplink coordination scenario of multiple access points is achieved.
Patent AU-2021240815-A1 (AU)
Title: An apparatus and method for reducing drag on moving vehicles
Inventor: MARTIN TIMOTHY SEAN CHRISTOPHER
IPC: B62K19/00
Filed: 2021-03-10
Abstract: An apparatus for reducing drag and wake formation behind moving vehicles such as road transport vehicles, motor cycles and bicycles including electric bicycles comprising one or more vents, each of those vents having a proximal end and a distal end, both ends being open and positioned and aligned longitudinally in the direction of travel in such a way as to addressing wake and boundary layer formation of a moving vehicle, said vents, positioned spaced from turbulent rear surfaces of the vehicle and affixed to the main body of the vehicle by one or more connecting members.
Patent AU-2021243461-A1 (AU)
Title: Methods and devices for cell based assays
Inventor: FOWLER STEPHEN
IPC: C12M1/30
Filed: 2021-03-22
Abstract: The present invention provides cell assay systems and its use in cell based assays.
Patent AU-2021248631-A1 (AU)
Title: Surface conditioning of railway tracks or wheels
Inventor: SWAN JULIAN
IPC: H05H1/00
Filed: 2021-04-06
Abstract: A surface conditioning (1) device for railway track rails (2) and/or railway vehicle wheels (7), the device comprising: a DC power supply (3); a supply of gas (9); a plasma delivery head (13) connected to receive DC power from said power supply (3) and gas from said gas supply (9); and an igniter (6) for igniting said gas in said plasma delivery head (13): wherein, in use, plasma is generated within said delivery head (13) by ignition of said gas in said delivery head (13), and plasma with gas is blown from the delivery head onto a railway track rail (2) and/or railway vehicle wheel (7), thereby to condition said rail (2) and/or wheel (7).
Patent AU-2021250199-A1 (AU)
Title: Deuterated oxophenylarsine compound and use thereof
Inventor: HUANG FUDE
IPC: A61P1/16
Filed: 2021-03-31
Abstract: Disclosed are a deuterated oxophenylarsine, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing a pharmaceutically acceptable carrier and the deuterated oxophenylarsine. The deuterated oxophenylarsine can be used for treating and preventing cancers and related diseases.
Patent AU-2021254641-A1 (AU)
Title: Treatment of cholestatic pruritus
Inventor: BOUDES POL
IPC: A61K31/192
Filed: 2021-10-22
Abstract: Treatment of cholestatic pruritus by therapy with seladelpar or a salt thereof.  
-19-
Patent AU-2021279072-A1 (AU)
Title: Sealed storage tanks and methods of making the same
Inventor: HARVEY ANDRE
IPC: B60K15/03
Filed: 2021-05-27
Abstract: Various embodiments disclosed relate to a sealed storage tank. The sealed storage tank includes a first polymeric layer. The sealed storage tank further includes a second polymeric layer continuously welded to the first polymeric layer to form the sealed storage tank. The sealed storage tank further includes an optional vent formed in the first polymeric layer or the second polymeric layer. The sealed storage tank can be configured to hold at least 13,000 liters of liquid.
Patent AU-2021285040-A1 (AU)
Title: Synthetic santalene synthases
Inventor: STYLES MATTHEW QUINN
IPC: C12P5/00
Filed: 2021-06-01
Abstract: Disclosed are santalene synthases with improved product profile and methods for improving santalene synthases. The invention further relates to santalene compositions produced by fermentation that have a greater beta-santalene content than alpha-santalene content.
Patent AU-2021285983-A1 (AU)
Title: Novel OMNI-59, 61, 67, 76, 79, 80, 81, and 82 CRISPR nucleases
Inventor: IZHAR LIOR
IPC: C12N15/113
Filed: 2021-06-04
Abstract: The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence selected from the group consisting of SEQ ID NOs: 1-8 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
Patent AU-2021290237-A1 (AU)
Title: Nasal cannula
Inventor: VAN BEURDEN JASON
IPC: A61M16/06
Filed: 2021-12-21
Abstract: A nasal cannula arrangement for use as part of systems for delivery respiratory gases to a patient is 
disclosed. The nasal cannula arrangement includes a manifold part adapted to receive gases from a 
5 delivery conduit. The manifold includes one but preferably a pair of prongs extending upward and 
curving towards the rear of the manifold. The prongs are inserted into the nostrils of the patient 
and deliver gases to a patient. The prongs have a cut out on the rear side of the prongs. The cut out 
forms a gases outlet in the prongs and are shaped such that the area of the cut out area is greater 
than the cross sectional area of the prongs at the entry point to the prongs.  
0
Patent AU-2021292312-A1 (AU)
Title: High speed nut cracking apparatus
Inventor: SAVAGE BASIL W
IPC: A23N5/00
Filed: 2021-06-17
Abstract: A nut cracking apparatus has a frame with a rotatable turret mounted thereto. A plurality of nut cracking units in the rotatable turret comprise pistons movable from a retracted position to an extended position and crack dies aligned with the piston. Air is communicated through feed air passages in the rotatable turret to urge the pistons from a retracted to an extended position.
Patent AU-2021292406-A1 (AU)
Title: Controlled release granulations of water-soluble active pharmaceutical ingredients
Inventor: KARABORNI SAMI
IPC: A61K31/00
Filed: 2021-06-17
Abstract: Pharmaceutical granulations having a functional coating surrounding a core containing a water-soluble active pharmaceutical ingredient are disclosed. The functional coating provides for immediate release or controlled release of the active pharmaceutical ingredient. The pharmaceutical granulations can be used in oral pharmaceutical compositions.
Patent AU-2021299459-A1 (AU)
Title: Therapeutic powder applicator
Inventor: TREXLER JONATHAN BRUCE
IPC: A61M13/00
Filed: 2021-06-28
Abstract: Therapeutic powder applicators and their methods of operation are described. In some embodiments, a first flow of gas may flow through a distal porous portion of a chamber containing a therapeutic powder. This gas may fluidize and entrain the therapeutic powder and flow the entrained powder through an outlet that is in fluid communication with the chamber.
Patent AU-2021306678-A1 (AU)
Title: Device for determining the level of haemoglobin or haematocrit of a circulating liquid
Inventor: CHOLLET STÉPHANE
IPC: G01N21/31
Filed: 2021-07-08
Abstract: The invention relates to a device for determining the level of haematocrit and/or the level of haemoglobin of a liquid circulating in the tubular portion (2), comprising two emitter-receiver assemblies (10; 20), each emitter-receiver assembly (10; 20) comprising a light source (11; 21) and a light sensor (12; 22) intended to be arranged on either side of the tubular portion (2) at a region of circulation of the liquid for a transmission measurement; the light source (11; 21) of each of the two emitter-receiver assemblies (10; 20) being configured to emit light beams at an emission wavelength chosen to correspond with an isobestic point of haemoglobin; each emitter-receiver assembly (10; 20) further comprising a system (13; 23) for collimating the light beam emitted from the corresponding light source (11; 21) towards the corresponding light sensor (12; 22).
Patent AU-2021307875-A1 (AU)
Title: Dispensing cup
Inventor: PATON MIKE
IPC: B65D83/04
Filed: 2021-07-02
Abstract: Described herein is dispensing cup for use with medicaments, which dispensing cup in use allows for the patient to (self) administer an oral medicament (tablet or capsule) without the need to come into direct (skin) contact with such medicament.
Patent AU-2021318560-A1 (AU)
Title: Combinatory treatment of SMA with saRNA and mRNA modulators
Inventor: LI LONGCHENG
IPC: C12N15/113
Filed: 2021-07-29
Abstract: Provided herein are methods and compositions related to combinations of (a) agents that increase the expression of SMN2 gene or protein, and (b) modulators of SMN2 mRNA splicing or stability that increase the production of functional SMN2 mRNA and SMN protein, and their use in treating SMA and related conditions or diseases. In certain embodiments, the methods relate to using SMN2 saRNA and SMN2 mRNA modulators for diminishing the symptoms of SMA.
Patent AU-2021322736-A1 (AU)
Title: Nicotinamide mononucleotide derivatives and use thereof in the treatment and prevention of an antineoplastic-induced toxicity
Inventor: BERMOND GUILLAUME
IPC: A61K31/706
Filed: 2021-08-06
Abstract: The present invention relates to nicotinamide mononucleotide derivatives of Formula (I) for use in the treatment and/or prevention of an antineoplastic-induced toxicity. The present invention further relates to pharmaceutical compositions comprising compounds of Formula (I) for use in the treatment and/or prevention of an antineoplastic-induced toxicity.
Patent AU-2021331854-A1 (AU)
Title: Pharmaceutical composition of single dosage form for treating or preventing hypertension and hyperlipidemia
Inventor: KIM JI YEON
IPC: A61K31/4164
Filed: 2021-08-25
Abstract: The present invention provides a pharmaceutical composition of a single dosage form for treating hypertension and hyperlipidemia. According to the present invention, a composition containing a drug is mixed and formulated in a single compartment form, and thus the stability and uniform dissolution rate of the drug are ensured, thereby simplifying the manufacturing process and allowing the process cost to be reduced, and allowing a bioequivalent formulation as compared to a conventional single formulation to be obtained.
Patent AU-2021335193-A1 (AU)
Title: Tracking an implantable device powered using ultrasonic waves
Inventor: KAY JOSHUA
IPC: H02J50/15
Filed: 2021-08-24
Abstract: Method and system embodiments for discovering or tracking a device implantable in a subject using ultrasonic waves are described. The method for tracking the implantable device can include establishing a synchronization state with the implantable device, estimating a location of the implantable device, and determining whether to maintain or to adjust were an ultrasonic beam is being focused based on ultrasonic signal strength. The method for discovering an implantable device powered using ultrasonic waves can include emitting an ultrasonic beam to successively focus on a plurality of focal points, receiving ultrasonic backscatter corresponding to the ultrasonic beam focused on the focal point, and comparing the received ultrasonic backscatter with a predetermined pattern associated with the implantable device to be discovered to generate a score indicating how likely the ultrasonic backscatter comprises the predetermined pattern; and determining a location of the implantable device from based on the scores.
Patent AU-2021336270-A1 (AU)
Title: Image processing systems and methods of using the same
Inventor: VIERING KIRSTEN
IPC: G06T7/33
Filed: 2021-08-27
Abstract: A method of generating a color image using a monochromatic image sensor. The method includes sequentially illuminating a surface in a plurality of colors, one color at a time. The monochromatic image sensor captures a plurality of image frames of the surface based on the plurality of colors. The plurality of image frames are identified, and at least one feature in the target of the plurality of image frames is highlighted. Color intensities of the plurality of image frames are normalized. A color intensity map of the target for each of the plurality of image frames is generated. A correlation score is determined by comparing each color intensity map of the plurality of image frames. The color image is generated based on the correlation score.
Patent AU-2021336883-A1 (AU)
Title: Glucose alert prediction horizon modification
Inventor: JEPSON LAUREN HRUBY
IPC: A61B5/145
Filed: 2021-09-01
Abstract: Data describing glucose measurements is received from a continuous glucose monitoring (CGM) system worn by a user and predicted glucose values during a future time period are generated for the user based on the data. A determination is made that at least one of the predicted glucose values satisfies a threshold value for an alert, which is associated with a prediction horizon that defines an amount of time prior to satisfaction of the threshold value for communicating the alert to the user. Output of the alert is caused responsive to determining that the at least one predicted glucose value satisfies the threshold value for the alert within the prediction horizon, relative to a current time. The prediction horizon is modified based on a user response to the alert. Output of a subsequent instance of the alert is caused based on the modified prediction horizon.
Patent AU-2021351927-A1 (AU)
Title: Biodegradable polymer delivery system for extended delivery of testosterone
Inventor: VAN HOVE AMY
IPC: A61K31/568
Filed: 2021-09-24
Abstract: Disclosed herein are biodegradable poly(lactide-co-glycolide) (PLG) polymer compositions that are administered into the body with syringes or needles and that are utilized to deliver a testosterone into the body over an extended period of time.
Patent AU-2021361780-A1 (AU)
Title: Photovoltaic power supply system and control method therefor, and air conditioning unit
Inventor: CHEN NINGNING
IPC: H02J3/28
Filed: 2021-07-12
Abstract: Disclosed are a photovoltaic power supply system and a control method therefor, and an air conditioning unit. The system comprises: a photovoltaic cell panel; a direct-current bus; a DC/DC converter, one end of which is connected to the photovoltaic cell panel, and the other end of which is connected to the direct-current bus; and a switch assembly arranged in parallel with the DC/DC converter, wherein one end of the switch assembly is connected to the photovoltaic cell panel, and the other end thereof is connected to the direct-current bus, and the switch assembly is used for controlling a grid connection mode of the photovoltaic cell panel. When the switch assembly is turned off, the photovoltaic cell panel is connected to the direct-current bus by means of the DC/DC converter; and when the switch assembly is turned on, the photovoltaic cell panel is directly connected to the direct-current bus.
Patent AU-2021401817-A1 (AU)
Title: Preparation of nucleic acid samples for sequencing
Inventor: LARSON MATTHEW
IPC: C12Q1/6855
Filed: 2021-12-18
Abstract: Compositions and methods are provided for amplifying nucleic acids, including cell free nucleic acid fragments, in preparation for sequencing. Methods are provided for making circularized nucleic acid templates having the structure [T]-[PS1]-[L]-[PS2] or [PS1]-[L]-[PS2]-[T'], where (a) T is a target nucleic acid and T' is a complement to a target nucleic acid; (b) each of PS1 and PS2 is a nucleic acid primer site; (c) L is a linker having a primer extension reaction terminating organic molecule; and the structure is circularized by binding a 5' end thereof to a 3' end thereof. Target sequences in the circularized templates are amplified by binding to PS1 a primer complimentary to PS1 and binding to PS2 a primer complimentary to PS2 and copying the target sequences by a primer extension reaction. Advantages include a reduction in ligation steps, which can result in fewer clean up steps and improved library conversion efficiency.
Patent AU-2021440597-A1 (AU)
Title: Composition and method for oral treatment of leukemia
Inventor: NARENDRAN ARU
IPC: A61K31/522
Filed: 2021-04-16
Abstract: A method of treating a mammalian subject 
having hematologic, non-tumorous cancer cells is 
disclosed. The method comprises the steps of: (A) 
administering to such a mammalian subject a 
therapeutically effective amount of a halogenated 
xanthene, a pharmaceutically acceptable salt or a C1-C4 
alkyl ester thereof as a first cancer cytotoxic agent 
dissolved or dispersed in a pharmaceutically acceptable 
aqueous medium. The mammalian subject is maintained 
for a period of time sufficient to induce death of 
hematologic, non-tumorous cancer cells. A contemplated 
administration is typically repeated. A contemplated 
treatment method can also be carried out in conjunction 
with administration to said mammalian subject of a 
second therapeutically effective amount of a second, 
differently-acting cancer cytotoxic agent dissolved or 
dispersed in a pharmaceutically acceptable medium. The 
second cancer cytotoxic agent can be a small molecule 
or an intact antibody or paratope-containing portion 
thereof.
Patent WO-2022256873-A1 (WO)
Inventor: FRASER MARK ANDREW
IPC: E02D29/02
Filed: 2022-06-09
Abstract: La présente invention concerne un système de cloisons modulaires comprenant des modules de cloison destinés à former une paire de cloisons ; et des espaceurs pour espacer les cloisons. De manière avantageuse, le système peut être fourni en kit sous la forme d'un système prêt-à-monter.
Patent AU-2022202422-A1 (AU)
Title: Syringe devices
Inventor: ROLFS BRYAN E
IPC: A61M5/315
Filed: 2022-04-12
Abstract: Described herein are syringe devices comprising a syringe including a 
therapeutic dose of at least one drug and a stopper. The syringe is housed and/or 
placed in an encasement. The plunger assembly can include a plunger, an actuator, 
and a spacer, wherein the plunger assembly is configured to move the stopper a 
predetermined distance without a user touching the plunger. Methods of assembling 
and using the syringe devices are also described.
Patent AU-2022217903-A1 (AU)
Title: Reduction of gene expression for the use for treating acne
Inventor: JULIA VALERIE
IPC: A61K9/107
Filed: 2022-02-07
Abstract: Disclosed herein are methods for treatment of a skin disorders using pharmaceutical compositions that reduces the expression of and/or inhibit the activity of various genes including chemokine (C-X-C motif) ligands such as CXCL13 and XCL1, and matrix-metalloproteinases such as MMP12 and MMP13. The pharmaceutical compositions effectively act on epidermal differentiation and proliferation as well as on innate and adaptive immune cells in pathogenesis of skin disorders such as acne.
Patent AU-2022221544-A1 (AU)
Title: Systems and methods for tissue removal
Inventor: WIXEY MATTHEW A
IPC: A61B17/34
Filed: 2022-08-26
Abstract: A system for removing a tissue specimen through a body opening defining a 
tissue margin. The system comprises a shield including a band made of flexible cut
resistant material; the band having an inner surface and an outer surface 
interconnected by a top end and a bottom end and by a first end and a second end. The 
band is configured to define a central lumen having a longitudinal axis. The central 
lumen has a lumen diameter that is perpendicular to the longitudinal axis. The band is 
split such that the band is movable into a reduced configuration where at least a portion 
of the outer surface at the first end overlaps and is in juxtaposition with the inner surface 
at the second end to form a spiral and define an overlapping portion; the shield being 
configured to have a variable lumen diameter by varying the overlapping portion. The 
system also comprises a locking mechanism configured to fix the lumen diameter. The 
locking mechanism includes a plurality of inner abutments formed on the inner surface 
and a plurality of outer abutments formed on the outer surface. Each of the plurality of 
inner abutments being configured to contact one of the plurality of outer abutments or 
the first end to prevent reduction of the lumen diameter in a locked configuration.  
A portion of the band is jogging outwardly to form a ridge in the inner surface defining 
an increased lumen diameter.
Patent AU-2022228742-A1 (AU)
Title: Process for producing a liquid herbicidal composition
Inventor: MONDAL ACHINTYA
IPC: A01N57/20
Filed: 2022-03-03
Abstract: The present invention relates to an improved process for producing a liquid herbicidal composition of single isomer of glufosinate salt and/or agronomically acceptable salts thereof.
Patent AU-2022231182-A1 (AU)
Title: A delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer
Inventor: GARCIA JOSE GABRIEL
IPC: A61K39/44
Filed: 2022-03-01
Abstract: This invention provides a molecular conjugate of anticancer compounds and imaging agents, generally as a cancer therapy comprising an antagonist of a cell surface opioid receptor such as a delta opioid receptor, specific to a target cell, an imaging agent, and an immune modulatory molecule, such as a T cell modulator, conjugated to the opioid receptor antagonist. The target cell can be a cell responsible for development of a disease in a subject, for example, a cancer cell. In certain embodiments, the immune modulatory molecule is an immune effector antibody. A method of treating a disease is provided comprising administering to a patient a therapeutically effective amount of the compounds or compositions of this invention to the patient. The disease may be treating cancer.
Patent AU-2022232196-A1 (AU)
Title: Transmembrane neoantigenic peptides
Inventor: AMIGORENA SEBASTIAN
IPC: A61K39/00
Filed: 2022-03-11
Abstract: The present disclosure provides transmembrane chimeric proteins derived from transposable element (TE)-exon fusion transcripts, as well as nucleic acids, antibodies, CARs, non-HLA restricted TCR and immune cells targeting such chimeric proteins that can be used in cancer therapy.
Patent AU-2022242653-A1 (AU)
Title: Squeezable tube dispenser
Inventor: TATU FRANCIS
IPC: B65D35/10
Filed: 2022-02-04
Abstract: A squeezable tube dispenser including a body, a nozzle, and a closure component. The body has an interior cavity for containing a substance. The nozzle is coupled to the body adjacent to an open top end of the body. The closure component includes a cover member that defines a cover cavity and a cap member protruding from an inner surface of the cover member into the cover cavity. The cap member defines a cap cavity. The cap member is detachably coupled to the nozzle via a friction fit with the nozzle nesting within the cap cavity of the cap member. The body and the cover member of the closure component are formed predominantly from a fibrous material and the nozzle and the cap of the closure component are formed from a plastic material. The squeezable tube dispenser has no more than 15% by weight of plastic.